SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ZIOPHARM Oncology, Inc. Announces Compelling Clinical Activity in Phase 1 Study of Ad-RTS IL-12 in Advanced Melanoma and Dosing of First Patient in Phase 2 Study